Moncef Slaoui resigns from Moderna board, divests $10M in stock

Moncef Slaoui, PhD, the former pharmaceutical executive who was named chief advisor of the government's Operation Warp Speed program, resigned from Moderna's board and will divest his $10 million in stock options, Business Insider reported. 

Dr. Slaoui had sat on the board of Moderna since 2017. Public officials, including Sen. Elizabeth Warren, D-Mass., have said his position with Moderna would have been a conflict of interest in his new role as head of COVID-19 vaccine development if he was incentivized to favor Moderna's vaccine.

Moderna told Business Insider that Dr. Slaoui resigned from the board last week and that he will divest his $10 million in stock options. 

Read the full article here.  

More articles on pharmacy:
32 of 40 drugs deemed critical for COVID-19 in short supply
Gilead strikes deal to manufacture remdesivir for 127 countries
How Civica Rx has responded to drug shortages caused by COVID-19

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers